Sintx Technologies Inc (SINT): Market Cap to Revenue

Symbol and logo of brand SINTX Technologies (SINT)

Sintx Technologies (SINT) is developing a mature portfolio of silicon nitride products, expanding the application of ceramics in energy and defense systems. The company's leadership is based on the creation of antibacterial nanostructures for implants. High processing precision is achieved through the robotization of sintering and grinding. P/S levels on this chart reflect the business valuation dynamics, where the parameter has stabilized at 3.20.

SINT SINTX Technologies P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Sintx Technologies (SINT)

- share price and consensus valuation forecast:
General company analysis:SINT Sintx Technologies Inc
Core merchandise of Sintx Technologies, Inc.

The P/S multiple reflects the market value of one ruble of revenue by comparing the total market capitalization of a business with its sales volume. Investors analyze this ratio to identify whether an asset is undervalued relative to its operational scale. The current P/S valuation helps determine if the market is overpaying for a company with a high dependency on external raw material suppliers. For Sintx Technologies (SINT), this indicator is critical, as distribution outsourcing directly impacts final turnover.

Competitors of Sintx Technologies

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Inc)|Price-to-Revenue Ratio ClearPoint Neuro Inc.|Market Cap to Revenue Stereotaxis Corporation (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical International - Market Cap to Sales Volume|vivani.com (VANI) - Price-to-Revenue Ratio|XTNT - Price-to-Revenue Coefficient|NMTC (NeuroOne Medical Technologies Corporation) - P/S Multiple|Modular Med (MODD) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Myomo, Inc (MYO)|Envoy Medical Inc - Market Cap to Revenue Ratio|Vivos Therapeutics - Market Cap to Revenue|Market Cap to Sales Volume NVNO (envveno.com)|TNON: Market Cap to Revenue|LFWD (ReWalk Robotics) - Market Cap to Revenue Ratio|AMIX (autonomix.com) - Market Cap to Revenue|INVO Fertility Corp - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue BBLG|AXNX (axonics.com) - Market Cap to Sales Volume|P/S Multiple BIOL|DYNT - Price to Sales|P/S Multiple FNA (Paragon 28)|INVO - Market Cap to Revenue